High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
暂无分享,去创建一个
H. Heslop | C. Rooney | M. Mims | F. Pane | M. Brenner | A. Leen | B. Savoldo | G. Dotti | C. Quintarelli | Sayyeda T Hasan | B. De Angelis | V. Hoyos | Santa Errichiello | L. Luciano | J. Shafer